Regression models for valve related morbidity
| Risk factors | p Value* | OR | 95% CI |
|---|---|---|---|
| *Wald test for variables included in the model. | |||
| AS, aortic stenosis; CI, confidence interval; OR, odds ratio. | |||
| Prosthetic valve endocarditis | |||
| Follow up duration (months) | 0.048 | 0.84 | 0.7 to 0.99 |
| Reoperation | |||
| BMI >29 kg/m2 | 0.05 | 8.0 | 1.0 to 63.4 |
| Surgical complications | <0.001 | 64 | 6.4 to 644.4 |
| AS + stentless biological valve | 0.08 | 11.6 | 0.8 to 177.3 |
| Bleeding events | |||
| Neurological disorders | 0.001 | 21.5 | 3.5 to 132.5 |
| Peripheral occlusive arterial disease | 0.028 | 9.7 | 1.3 to 73.7 |
| Mechanical valve + age >75 years | 0.007 | 18.9 | 2.2 to 163.0 |
| Stroke | |||
| Atrial fibrillation at discharge | 0.012 | 4.1 | 1.4 to 12.5 |
| Female + AS | 0.033 | 3.2 | 1.1 to 9.5 |
| Female + internal carotid artery stenosis | 0.001 | 12.1 | 2.7 to 53.6 |
| Stentless biological valve + NYHA IV | 0.007 | 9.5 | 1.9 to 48.4 |